A phenotypic screen to identify hypertrophy-modulating microRNAs in primary cardiomyocytes

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 1, 2012, Pages 13-20

  Jentzsch, Claudia ^a,b   Leierseder, Simon ^a,b   Loyer, Xavier ^a,b,e   Flohrschütz, Isabell ^a   Sassi, Yassine ^a   Hartmann, Dorothee ^c   Thum, Thomas ^c   Laggerbauer, Bernhard ^a   Engelhardt, Stefan ^a,b,d  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d Munich Heart Alliance   (Germany)

^e PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

Author keywords

Cardiomyocyte hypertrophy; MicroRNA; MiR 133a; MiR 212; MiR 22; MiR 27; MiR 30; MiR 365; Phenotypic screen

Indexed keywords

MICRORNA; MICRORNA 126; MICRORNA 133A; MICRORNA 212; MICRORNA 22; MICRORNA 27A; MICRORNA 27B; MICRORNA 30C; MICRORNA 30D; MICRORNA 365; UNCLASSIFIED DRUG;

ALGORITHM; ARTICLE; ASSAY; AUTOMATION; CARDIOMYOCYTE HYPERTROPHY; CELL DENSITY; CELL SIZE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENETIC SCREENING; HEART MUSCLE CELL; MICROSCOPY; MOLECULAR LIBRARY; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; RNA LIBRARY;

ANIMALS; CELL ENLARGEMENT; CELL SEPARATION; CELLS, CULTURED; GENE EXPRESSION PROFILING; HIGH-THROUGHPUT SCREENING ASSAYS; MICRORNAS; MYOCYTES, CARDIAC; PHENOTYPE; PRIMARY CELL CULTURE; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; TRANSFECTION;

RATTUS;

EID: 84155186597     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.07.010     Document Type: Article

References (60)

1. Heineke J., Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006, 7:589-600.
2. Olson E.N. A decade of discoveries in cardiac biology. Nat Med 2004, 10:467-474.
3. Frey N., Olson E.N. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 2003, 65:45-79.
4. Drazner M.H. The progression of hypertensive heart disease. Circulation 2011, 123:327-334.
5. Artham S.M., Lavie C.J., Milani R.V., Patel D.A., Verma A., Ventura H.O. Clinical impact of left ventricular hypertrophy and implications for regression. Prog Cardiovasc Dis 2009, 52:153-167.
6. Latronico M.V., Condorelli G. microRNAs in hypertrophy and heart failure. Exp Biol Med 2011, 236:125-131. (Maywood).
7. Liu N., Olson E.N. MicroRNA regulatory networks in cardiovascular development. Dev Cell 2010, 18:510-525.
8. Taft R.J., Pang K.C., Mercer T.R., Dinger M., Mattick J.S. Non-coding RNAs: regulators of disease. J Pathol 2010, 220:126-139.
9. Zhao Y., Srivastava D. A developmental view of microRNA function. Trends Biochem Sci 2007, 32:189-197.
10. Ghildiyal M., Zamore P.D. Small silencing RNAs: an expanding universe. Nat Rev Genet 2009, 10:94-108.
11. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
12. Orom U.A., Lund A.H. Experimental identification of microRNA targets. Gene 2010, 451:1-5.
13. Small E.M., Frost R.J., Olson E.N. MicroRNAs add a new dimension to cardiovascular disease. Circulation 2010, 121:1022-1032.
14. van Rooij E., Sutherland L.B., Liu N., Williams A.H., McAnally J., Gerard R.D., et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 2006, 103:18255-18260.
15. Tatsuguchi M., Seok H.Y., Callis T.E., Thomson J.M., Chen J.F., Newman M., et al. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 2007, 42:1137-1141.
16. Thum T., Galuppo P., Wolf C., Fiedler J., Kneitz S., van Laake L.W., et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 2007, 116:258-267.
17. Thum T., Gross C., Fiedler J., Fischer T., Kissler S., Bussen M., et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008, 456:980-984.
18. Lin Z., Murtaza I., Wang K., Jiao J., Gao J., Li P.F. miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy. Proc Natl Acad Sci USA 2009, 106:12103-12108.
19. Ikeda S., He A., Kong S.W., Lu J., Bejar R., Bodyak N., et al. MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol Cell Biol 2009, 29:2193-2204.
20. Martins P.A., Salic K., Gladka M.M., Armand A.S., Leptidis S., el Azzouz H., et al. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol 2010, 12:1220-1227.
21. Small E.M., Olson E.N. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011, 469:336-342.
22. Krausz E. High-content siRNA screening. Mol Biosyst 2007, 3:232-240.
23. Conrad C., Gerlich D.W. Automated microscopy for high-content RNAi screening. J Cell Biol 2010, 188:453-461.
24. Lam L.T., Lu X., Zhang H., Lesniewski R., Rosenberg S., Semizarov D. A microRNA screen to identify modulators of sensitivity to BCL2 inhibitor ABT-263 (navitoclax). Mol Cancer Ther 2010, 9:2943-2950.
25. Santhakumar D., Forster T., Laqtom N.N., Fragkoudis R., Dickinson P., Abreu-Goodger C., et al. Combined agonist-antagonist genome-wide functional screening identifies broadly active antiviral microRNAs. Proc Natl Acad Sci USA 2010, 107:13830-13835.
26. Cheng A.M., Byrom M.W., Shelton J., Ford L.P. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 2005, 33:1290-1297.
27. Monovich L., Koch K.A., Burgis R., Osimboni E., Mann T., Wall D., et al. Suppression of HDAC nuclear export and cardiomyocyte hypertrophy by novel irreversible inhibitors of CRM1. Biochim Biophys Acta 2009, 1789:422-431.
28. Callis T.E., Pandya K., Seok H.Y., Tang R.H., Tatsuguchi M., Huang Z.P., et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 2009, 119:2772-2786.
29. Claycomb W.C., Lanson N.A.J., Stallworth B.S., Egeland D.B., Delcarpio J.B., Bahinski A., et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 1998, 95:2979-2984.
30. Kimes B.W., Brandt B.L. Properties of a clonal muscle cell line from rat heart. Exp Cell Res 1976, 98:367-381.
31. Hescheler J., Meyer R., Plant S., Krautwurst D., Rosenthal W., Schultz G. Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ Res 1991, 69:1476-1486.
32. Landstrom A.P., Kellen C.A., Dixit S.S., van Oort R.J., Garbino A., Weisleder N., et al. Junctophilin-2 expression silencing causes cardiocyte hypertrophy and abnormal intracellular calcium-handling. Circ Heart Fail 2011, 4:214-223.
33. Watkins S.J., Borthwick G.M., Arthur H.M. The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In Vitro Cell Dev Biol Anim 2011, 47:125-131.
34. Simpson P., McGrath A., Savion S. Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ Res 1982, 51:787-801.
35. Bush E., Fielitz J., Melvin L., Martinez-Arnold M., McKinsey T.A., Plichta R., et al. A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway. Proc Natl Acad Sci USA 2004, 101:2870-2875.
36. Song K., Backs J., McAnally J., Qi X., Gerard R.D., Richardson J.A., et al. The transcriptional coactivator CAMTA2 stimulates cardiac growth by opposing class II histone deacetylases. Cell 2006, 125:453-466.
37. Depre C., Shipley G.L., Chen W., Han Q., Doenst T., Moore M.L., et al. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat Med 1998, 4:1269-1275.
38. Zhang C.G., Jia Z.Q., Li B.H., Zhang H., Liu Y.N., Chen P., et al. Beta-catenin/TCF/LEF1 can directly regulate phenylephrine-induced cell hypertrophy and Anf transcription in cardiomyocytes. Biochem Biophys Res Commun 2009, 390:258-262.
39. Cao D.J., Wang Z.V., Battiprolu P.K., Jiang N., Morales C.R., Kong Y., et al. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc Natl Acad Sci USA 2011, 108:4123-4128.
40. Usui S., Maejima Y., Pain J., Hong C., Cho J., Park J.Y., et al. Endogenous muscle atrophy F-Box mediates pressure overload-induced cardiac hypertrophy through regulation of nuclear factor-{kappa}B. Circ Res 2011, [Epub ahead of print].
41. van Rooij E., Marshall W.S., Olson E.N. Toward microRNA-based therapeutics for heart disease: the sense in antisense. Circ Res 2008, 103:919-928.
42. Duisters R.F., Tijsen A.J., Schroen B., Leenders J.J., Lentink V., van der Made I., et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 2009, 104:170-178. 6p following 178.
43. Li J., Donath S., Li Y., Qin D., Prabhakar B.S., Li P. miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway. PLoS Genet 2010, 6:e1000795.
44. Martinez I., Cazalla D., Almstead L.L., Steitz J.A., DiMaio D. miR-29 and miR-30 regulate B-Myb expression during cellular senescence. Proc Natl Acad Sci USA 2011, 108:522-527.
45. Agrawal R., Tran U., Wessely O. The miR-30 miRNA family regulates Xenopus pronephros development and targets the transcription factor Xlim1/Lhx1. Development 2009, 136:3927-3936.
46. Joglekar M.V., Patil D., Joglekar V.M., Rao G.V., Reddy D.N., Mitnala S., et al. The miR-30 family microRNAs confer epithelial phenotype to human pancreatic cells. Islets 2009, 1:137-147.
47. Yu F., Deng H., Yao H., Liu Q., Su F., Song E. Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene 2010, 29:4194-4204.
48. Patel J.B., Appaiah H.N., Burnett R.M., Bhat-Nakshatri P., Wang G., Mehta R., et al. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22. Oncogene 2010.
49. Li J., Liang S., Yu H., Zhang J., Ma D., Lu X. An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer. Gynecol Oncol 2010, 119:543-548.
50. Zhang J., Yang Y., Yang T., Liu Y., Li A., Fu S., et al. microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br J Cancer 2010, 103:1215-1220.
51. Ting Y., Medina D.J., Strair R.K., Schaar D.G. Differentiation-associated miR-22 represses Max expression and inhibits cell cycle progression. Biochem Biophys Res Commun 2010, 394:606-611.
52. Bar N., Dikstein R. miR-22 forms a regulatory loop in PTEN/AKT pathway and modulates signaling kinetics. PLoS One 2010, 5:e10859.
53. Poliseno L., Salmena L., Riccardi L., Fornari A., Song M.S., Hobbs R.M., et al. Identification of the miR-106b ~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal 2010, 3:ra29.
54. Xu X.D., Song X.W., Li Q., Wang G.K., Jing Q., Qin Y.W. Attenuation of microRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy. J Cell Physiol May 26, 2011, [Epub ahead of print]. 10.1002/jcp.22852.
55. Guo L., Huang Z.X., Chen X.W., Deng Q.K., Yan W., Zhou M.J., et al. Differential expression profiles of microRNAs in NIH3T3 cells in response to UVB irradiation. Photochem Photobiol 2009, 85:765-773.
56. Maes O.C., Sarojini H., Wang E. Stepwise up-regulation of microRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts. J Cell Physiol 2009, 221:109-119.
57. Wang X.Y., Wu M.H., Liu F., Li Y., Li N., Li G.Y., et al. Differential miRNA expression and their target genes between NGX6-positive and negative colon cancer cells. Mol Cell Biochem 2010, 345:283-290.
58. Ohlsson Teague E.M., Van der Hoek K.H., Van der Hoek M.B., Perry N., Wagaarachchi P., Robertson S.A., et al. MicroRNA-regulated pathways associated with endometriosis. Mol Endocrinol 2009, 23:265-275.
59. Care A., Catalucci D., Felicetti F., Bonci D., Addario A., Gallo P., et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007, 13:613-618.
60. Chinchilla A., Lozano E., Daimi H., Esteban F.J., Crist C., Aranega A.E., et al. MicroRNA profiling during mouse ventricular maturation: a role for miR-27 modulating Mef2c expression. Cardiovasc Res 2011, 89:98-108.